Skip to content
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
KeyPediaKeyPedia
  • Company
  • Platform
  • Media
  • KeyPedia Lite
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. CSL Plasma Inc.
FDA Inspection•CSL Plasma Inc.•September 18, 2009

CSL Plasma Inc. – FDA Inspection, Sep 18, 2009

Record Details

This FDA Inspection record concerns CSL Plasma Inc., with an inspection on September 18, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
CSL Plasma Inc.
Inspection Date
September 18, 2009
Product Type
Drugs
Office
Center for Drug Evaluation and Research

ID · e9d271aa-0c29-4066-8ae7-f27a42dd2884

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
613842
FDA center
Human Drugs
Project area
Postmarket Surv. and Epidemiology

FDA Citations

5
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.160(a)Deviations from laboratory control requirements
  3. 21 CFR 314.80(c)(2)Interval
  4. 21 CFR 211.100(b)SOPs not followed / documented
  5. 21 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up

Full citation text and observation details available on the Dashboard.

Other FDA inspections of CSL Plasma Inc.

4
DateClassificationOfficeProject area
February 7, 2025VAIAtlanta District OfficeDrug Quality Assurance
February 6, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 20, 2012NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 17, 2010NAICenter for Drug Evaluation and ResearchDrug Quality Assurance

Other documents for CSL Plasma Inc.

4
Document
FDA Inspection 1260233 · February 7, 2025 
FDA Inspection 866535 · February 6, 2014 
FDA Inspection 765730 · January 20, 2012 
FDA Inspection 673006 · June 17, 2010 
View Company ProfileHave an account? Sign in to open in Dashboard

Or discuss it with

What you get

  1. A document

    One file.

    • One FDA document, such as a Form 483
    • Yours for life in your Library
    • Each has its own price
    here
  2. The profile

    All the documents, plus intelligence about the company.

    • Every CSL Plasma Inc. document on file
    • The KRA score, which a single document does not include
    • Observations and inspection history
  3. Access

    This, for every company on KeyPedia.

    • Combine profiles in one search
    • Search across any modality: products, industry types, drugs, devices and recalls
    • Track everything as it changes
    • Other agencies too, such as EMA, Health Canada and UK MHRA
    Browse free in KeyPedia Lite
KeyPedia
The intelligence layer for life sciences
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
Quick Links
HomePlatformUse CasesHardwarePricingResearchOur TechnologyFAQMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPrograms & Partnerships
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.